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Abstract Vitamin D induces the expression of antimicrobial
peptides with activity against Staphylococcus aureus. Thus,
we studied the association between serum 25-
hydroxyvitamin D (25(OH)D) and S. aureus nasal coloniza-
tion and carriage. Nasal swabs, blood samples and clinical
data from 2,115 women and 1,674 men, aged 30–87 years,
were collected inthe Tromsø Staphand Skin Study2007–08,
as part of the population-based sixth Tromsø Study.
Multivariate logistic regression analyses were stratified
by recognized risk factors for S. aureus carriage: sex, age
and smoking. In non-smoking men, we observed a 6.6%
and 6.7% decrease in the probability of S. aureus
colonization and carriage, respectively, by each 5 nmol/
l increase in serum 25(OH)D concentration (P<0.001 and
P=0.001), and serum 25(OH)D>59 nmol/l and ≥75 nmol/
l as thresholds for ~30% and ~50% reduction in S. aureus
colonization and carriage. In non-smoking men aged 44–
60 years, the odds ratio for S. aureus colonization was
0.44 (95% confidence interval, 0.28−0.69) in the top
tertile of serum 25(OH)D versus the bottom tertile. In
women and smokers there were no such associations. Our
study supports that serum vitamin D is a determinant of S.
aureus colonization and carriage.
Introduction
The burden of disease from Staphylococcus aureus is high
and worrying due to widespread antimicrobial resistance
[1]. Nasal carriage of S. aureus is a major risk factor for
infections with the bacterium [2–4]. Since about 20% of
healthy adults are persistent nasal carriers [4], prevention or
elimination of the carrier state may contribute substantially
in reducing the S. aureus disease burden. However, there is
still limited evidence in relation to modifiable risk factors
for the carrier state [5]. Smoking is so far the only
protective factor observed across different studies [6, 7],
while serum glucose levels [6] and oral contraceptives use
[8] have been positively associated with S. aureus nasal
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tion was recently observed between serum vitamin D levels
and risk of methicillin resistant S. aureus (MRSA) nasal
carriage, while no association was found for methicillin
sensitive S. aureus (MSSA) [9].
Vitamin D has direct effects on immunity modulated by
the vitamin D receptor (VDR) present in immune cells.
Binding of VDR to its responsive element induces
expression of antimicrobial peptides (i.e. cathelicidin and
β-defensin) with activity against S. aureus in vitro [10–12].
Serum 25-hydroxyvitamin D (25(OH)D) provides an
overall estimate of vitamin D status and integrates vitamin
D derived from endogenous production from sun exposure,
and from dietary intake [13]. Importantly, populations
living at higher latitudes with periodic lack of photosyn-
thesis show larger proportions of vitamin D insufficiency
and increased risk of several chronic and some infectious
diseases [13–18]. In the present Norwegian study popula-
tion, the Tromsø Study, we observed variation in serum 25
(OH)D levels by season, age, body weight, intake of
vitamin D, physical activity and smoking [19, 20], and
variation in S. aureus carriage rates by sex and age [21].
Further studies of the role of vitamin D in the host-
microbe interplay may give novel clues to targets for
prevention of S. aureus carriage and infection as well as
underlying biological mechanisms. We therefore examined
the cross-sectional relationship between serum 25(OH)D
concentration and S. aureus nasal colonization and carriage
in 4,000 men and women participating in the Tromsø Staph
and Skin Study (TSSS), a sub-study of the sixth Tromsø
Study, evaluating both possible dose-response and thresh-
olds for adequate immune response against S. aureus.
Subjects and methods
Population and study design: The Tromsø Staph and Skin
Study (TSSS)
The Tromsø Study is a longitudinal, multipurpose,
population-based study in the municipality of Tromsø,
Norway, 69°N. In the sixth Tromsø Study (October 2007–
December 2008), a total of 12,984 subjects (65.7%)
attended [22]. TSSS took place during October 2007 till
July 2008 and nasal swab cultures were collected from all
attendees aged 30–49 years and random samples of older
attendees (relative distribution of birth cohorts as in the
municipality). The 4,026 participants who had a first nasal
swab culture were invited to a repeated sample within a few
weeks (Fig. 1). Participants with missing data on serum 25
(OH)D (n=60) or smoking status (n=48) and those taking
antibiotics, either systemic or eye drops/ointments, within
24 h before nasal swabbing (first swab n=27, second swab
n=14) were excluded. We included 3,789 participants with
minimum one valid nasal swab culture for analysis of
S. aureus nasal colonization, and 2,780 participants with
two valid nasal swab cultures for the analysis of S. aureus
carriage (Fig. 1).
Information was obtained from questionnaires, interview,
clinical examinations and blood samples performed by
specially-trained healthcare workers according to stand-
ardised procedures. The study was approved by the
Regional Committee of Medical and Health Research
Ethics, North Norway.
Detection of S. aureus nasal colonization and carriage
Both anterior nares were sampled with a NaCl-moistened
sterile rayon-tipped swab that was placed in Amies charcoal
transport medium (Copan, Brescia, Italy). All specimens
were cultured within 3 days at the Department of
Microbiology and Infection Control, University Hospital
of North Norway (UNN), Tromsø. The swabs were plated
on chromID S. aureus and chromID™ MRSA agars
(bioMérieux, Marcy I’Etoile, France) and incubated for 48
hours at 35°C. Colony morphology on the agar plates was
Fig. 1 Study population: S. aureus colonization (single nasal swab
culture) and S. aureus carriage (repeated nasal swab culture).
aParticipants invited; <50 years: all, and ≥50 years: random samples.
bAntibiotics taken in the last 24 hours before visit: systemic or eye
drops/ointments.
cMedian time between repeated nasal swabs was
31 days
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positive colonies were confirmed as S. aureus by the
Staphaurex Plus agglutination test (Murex Diagnostic Ltd,
Dartford, UK). No MRSA was registered.
S. aureus colonization state was defined as positive or
negative for S. aureus in the first sample. Carrier state was
based on the culturing results of two consecutive samples;
carrier = two positive samples and non-carrier = one or no
positive sample [23].
Assessment of serum 25-hydroxyvitamin D concentrations
Non-fasting blood samples were drawn from an antecubital
vein, and sera were consecutively analysed for 25(OH)D by
immunometry (electrochemiluminescence immunoassay),
using an automated clinical chemistry analyser (Modular
E170; Roche Diagnostics [20, 24]). The total analytical
coefficient of variation was 7.3%. We recently showed that
smokers had 15–20% higher serum 25(OH)D than non-
smokers. However, this was not observed when using other
immunological and liquid-chromatography mass spectrom-
etry methods [19]. To this discrepancy, presently, we have
no explanation. Thus, non-smokers and smokers are
analysed separately.
Assessment of characteristics of the study population
Two self-administered structured questionnaires covered a
broad range of issues related to health and lifestyle. Body
height and weight were measured, and body mass index
was calculated (BMI kg/m
2)[ 22]. Use of antibiotics in the
last 24 hours was registered by interview.
Statistical analysis
Logistic regression models were used to study the association
between serum 25(OH)D and S. aureus colonization and
carriage; odds ratios (ORs) and 95% confidence intervals
(CIs) were determined. Due to lack of prior knowledge of
serum 25(OH)D thresholds for adequate immune response,
serum 25(OH)D tertiles were selected as suitable for the
samples; non-smokers were subdivided as: <44.9 nmol/l,
44.9–58.6 nmol/l, >58.6 nmol/l; and smokers: <59.6 nmol/l,
59.6–75.3 nmol/l, >75.3 nmol/l. Also, proposed cut-points
for vitamin D deficiency/insufficiency were examined (i.e. <
50.0, 50.0–<75.0, ≥75.0 nmol/l) [14] among non-smokers.
Selected characteristics of men and women in the different
serum 25(OH)D tertiles were compared by one-way ANOVA
and Kruskal-Wallis test for continuous variables and two-
sided Pearson chi-squared test for categorical variables.
We evaluated model fit and biological plausibility of
several covariates and the final multivariate models included
age, BMI, diabetes mellitus (yes/no), and calendar month
(2 months categories), and in smokers also number of
cigarettes smoked per day and total years smoked. Further
adjustment for education (< or ≥ college/university degree),
last hospitalization in 12 months (yes/no), recreational
physical activity (3 levels), and alcohol intake (< or ≥2t i m e s
a week) did not alter the multivariate risk estimates.
We studied whether age modified the association in
stratified logistic regression models using tertiles of age for
non-smokers grouped as: <44 years, 44–60 years,
>60 years.
Tests of reliability of the final analyses were done by
the Hosmer-Lemeshow goodness of fit test. Tests for linear
trend were performed by assigning consecutive integers to
each tertile of serum 25(OH)D, and testing whether the
slope coefficient differed from zero using the Wald chi-
square test. Test for interaction was done by inclusion of
the multiplicative term of the two predictor variables in
the model. Two-sided P values<0.05 were considered
statistically significant. STATA version 11.0 (StataCorp)
was used.
Results
The characteristics of the non-smoking and smoking TSSS
study population are shown in Tables 1 and 2, respectively.
Non-smoking population
Non-smokers constituted 80.7% (1,351 of 1,674) men and
78.3% (1,655 of 2,115) women. Mean serum 25(OH)D
concentration was 53.3 nmol/l in non-smoking men and
52.4 nmol/l in non-smoking women. For both sexes, high
serum 25(OH)D was associated with higher age, physical
activity level and alcohol intake, and in women, there was a
negative association with BMI (all P-values<0.05) (Table 1).
The prevalence of S. aureus nasal colonization and carriage
was 37.5% (506 of 1,351) and 34.1% (338 of 992) in men,
and 24.4% (403 of 1,655) and 21.3% (264 of 1,239) in
women, respectively.
There was an inverse dose-response relationship between
serum 25(OH)D and S. aureus nasal colonization and
carriage in non-smoking men (Fig. 2). The estimated beta
coefficient equals a 6.6% and a 6.7% decrease in the
probability of S. aureus colonization and carriage, respec-
tively, by each 5 nmol/l increase in serum 25(OH)D
concentration (P<0.001 and P=0.001; unadjusted). Fur-
thermore, in the multivariate logistic regression analysis we
observed a 35% and 33% reduction in colonization and
carriage risk in upper versus bottom tertiles of serum 25
(OH)D in men (OR 0.65, 95%CI 0.49–0.87, P for trend
0.004; and OR 0.67, 95%CI 0.48–0.95, P for trend 0.03,
respectively) (Table 3). Also, those with serum 25(OH)D
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almost half the risk of S. aureus colonization and carriage
(OR 0.54, 95%CI 0.35–0.84, P for trend 0.004; and OR
0.52, 95%CI 0.31–0.90, P for trend 0.02, respectively)
(Table 3). As S. aureus carriage rate in men is inversely
related to age [21], we stratified by age tertiles in the
multivariate logistic regression analysis. In the middle-age
tertile, age 44–60 years, OR for colonization and carriage in
top versus bottom tertile of serum 25(OH)D was 0.44 and
0.51 (95% CI 0.28–0.69, P for trend <0.001; and 95%CI
0.30–0.88, P for trend 0.02, respectively), while in younger
and older adult men no association was observed (P for
interaction 0.10 and 0.45, respectively) (results not shown
in figures or tables).
Table 1 The Tromsø Staph and Skin Study. Characteristics of non-smoking men and women by tertiles of serum 25(OH)D
Characteristic Single swab culture
Serum 25(OH)D (nmol/l)
Men (n=1,351
a) Women (n=1,655
a)
Tertile 1 Tertile 2 Tertile 3 P
b Tertile 1 Tertile 2 Tertile 3 P
b
<44.9 (n=438) 44.9–58.6 (n=464) >58.6 (n=449) <44.9 (n=566) 44.9–58.6 (n=537) >58.6 (n=552)
Age (years) 51.9 (12.8) 54.3 (12.8) 56.3 (12.3) <0.001 53.7 (14.2) 54.4 (12.9) 56.0 (12.4) 0.003
Ethnicity sami 10 (2.6) 8 (1.8) 6 (1.4) 0.50 9 (1.7) 9 (1.9) 7 (1.4) 0.84
Low education
c 250 (57.5) 256 (55.7) 257 (57.5) 0.81 317 (57.2) 308 (58.3) 324 (59.3) 0.78
BMI (kg/m
2) 27.5 (4.0) 27.7 (3.5) 27.1 (3.3) 0.05 27.4 (5.4) 26.8 (4.7) 25.9 (4.1) <0.001
Diabetes mellitus 13 (3.1) 24 (5.3) 4 (0.9) 0.001 26 (4.7) 21 (4.0) 21 (3.9) 0.77
Atopic eczema 30 (7.7) 32 (7.5) 32 (7.8) 0.99 52 (10.2) 42 (9.0) 43 (8.8) 0.72
Hospitalization
d 44 (10.2) 42 (9.1) 46 (10.4) 0.78 71 (12.6) 53 (10.1) 66 (12.2) 0.38
Low physical activity
e 91 (21.5) 77 (17.2) 54 (12.7) 0.003 118 (22.7) 77 (15.5) 60 (11.6) <0.001
High alcohol intake
f 86 (19.7) 115 (25.1) 126 (28.4) 0.01 71 (12.7) 100 (18.9) 136 (24.9) <0.001
Characteristic Repeated swab culture
Serum 25(OH)D (nmol/l)
Men (n=992
a) Women (n=1,239
a)
Tertile 1 Tertile 2 Tertile 3 P
b Tertile 1 Tertile 2 Tertile 3 P
b
<44.9 (n=329) 44.9–58.6 (n=346) >58.6 (n=317) <44.9 (n=431) 44.9–58.6 (n=390) >58.6 (n=418)
Age (years) 52.3 (12.6) 55.0 (12.7) 56.6 (12.3) <0.001 53.7 (13.9) 54.7 (12.8) 56.0 (11.9) 0.03
Ethnicity sami 7 (2.3) 6 (1.8) 5 (1.7) 0.83 9 (2.2) 3 (0.8) 7 (1.8) 0.31
Low education
c 196 (59.9) 193 (56.4) 180 (57.1) 0.63 240 (56.9) 227 (59.4) 250 (60.2) 0.59
BMI (kg/m
2) 27.6 (4.1) 27.7 (3.6) 27.2 (3.4) 0.13 27.4 (5.2) 26.8 (4.7) 26.1 (4.2) <0.001
Diabetes mellitus 9 (2.8) 21 (6.2) 2 (0.7) <0.001 22 (5.2) 13 (3.5) 17 (4.2) 0.46
Atopic eczema 21 (7.1) 27 (8.4) 19 (6.5) 0.64 40 (10.1) 30 (8.6) 33 (8.8) 0.74
Hospitalization
d 32 (9.9) 31 (9.0) 33 (10.5) 0.81 53 (12.4) 35 (9.2) 47 (11.4) 0.34
Low physical activity
e 67 (21.0) 59 (17.6) 37 (12.3) 0.02 83 (20.7) 53 (14.7) 55 (13.9) 0.02
High alcohol intake
f 63 (19.3) 88 (25.7) 90 (28.9) 0.02 51 (12.5) 75 (19.5) 108 (26.2) <0.001
Values are given as means (standard deviation) and numbers (%)
BMI body mass index
aNumbers may vary due to missing information
bKruskal Wallis test for continuous variables. Pearson chi-square test for categorical variables
cOnly education below college/university degree
dHospitalization in last 12 months
eSedentary recreational physical activity like watching TV
fAlcohol intake≥2 times per week
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inverse trend of the linear regression line in the serum 25
(OH)D–S. aureus colonization and carriage plots (P=0.25,
and P=0.22, respectively; unadjusted) (Fig. 2), but there
was no difference in S. aureus nasal colonization and
carriage risk between tertiles or categories (i.e. cut-off
values 50 and 75 nmol/l) of serum 25(OH)D (Table 3).
As general recommendations on vitamin D status in
adults do not differ by sex, we examined the total
population of non-smokers and observed a 3.8% and
4.4% decrease in S. aureus colonization and carriage risk
by each 5 nmol/l increase in serum 25(OH)D concentration,
respectively (P=0.001 and P=0.002; unadjusted) (Fig. 2).
Smoking population
In the smoking population, average vitamin D concen-
tration was higher than in non-smokers; mean serum 25
(OH)D concentration was 66.8 nmol/l in men and
71.3 nmol/l in women. In women, serum 25(OH)D was
positively associated with number of cigarettes smoked
per day and years of smoking (both P-values<0.05)
(Table 2) .T h ep r e v a l e n c eo fS. aureus nasal colonization
and carriage was 29.1% (94 of 323) and 24.5% (57 of 233)
in men, and 18.3% (84 of 460) and 15.2% (48 of 316) in
women, respectively. All prevalence rates were signifi-
cantly lower than in non-smokers (all P-values<0.05). We
did not observe any association between serum 25(OH)D
concentration and S. aureus nasal colonization or carriage
rates in top versus bottom tertile of serum 25(OH)D in either
male (multivariate model; colonization: OR 1.19; 95%CI
0.62–2.29, P for trend 0.66; and carriage: OR 1.33, 95%CI
0.53–3.33, P for trend 0.47) or female smokers (multivariate
model; colonization: OR 0.96, 95% CI 0.50–1.86, P for
trend 0.83; and carriage OR 1.49, 95%CI 0.59–3.77, P for
trend 0.48) (results not shown in figures or tables).
Discussion
In this large population-based study with repeated nasal
swab cultures we observed an inverse dose-response
Table 2 The Tromsø Staph and Skin Study. Characteristics of smoking men and women by tertiles of serum 25(OH)D
Characteristic Single swab culture
Serum 25(OH)D (nmol/l)
Men (n=323
a) Women (n=460
a)
Tertile 1 Tertile 2 Tertile 3 P
b Tertile 1 Tertile 2 Tertile 3 P
b
<59.6 (n=115) 59.6–75.3 (n=122) >75.3 (n=86) <59.6 (n =143) 59.6–75.3 (n=140) >75.3 (n=177)
Age (years) 51.1 (12.3) 51.9 (11.5) 53.0 (10.9) 0.35 52.1 (12.4) 53.4 (10.8) 52.1 (10.6) 0.40
BMI (kg/m
2) 26.7 (4.3) 26.8 (3.5) 26.9 (4.3) 0.99 27.0 (5.3) 25.6 (4.5) 24.7 (3.6) 0.001
No. of cigarettes/day 12.8 (9.6) 13.0 (6.6) 13.6 (6.0) 0.07 9.4 (6.9) 10.9 (4.7) 11.1 (5.2) 0.001
No. of years smoked 30.4 (12.8) 32.9 (11.5) 33.9 (11.7) 0.06 28.8 (11.1) 31.7 (10.2) 32.8 (9.8) 0.004
Characteristic Repeated swab culture
Serum 25(OH)D (nmol/l)
Men (n=233
a) Women (n=316
a)
Tertile 1 Tertile 2 Tertile 3 P
b Tertile 1 Tertile 2 Tertile 3 P
b
<59.6 (n=82) 59.6–75.3 (n=88) >75.3 (n=63) <59.6 (n=97) 59.6–75.3 (n=98) >75.3 (n=121)
Age (years) 50.8 (12.1) 53.1 (11.3) 54.0 (11.4) 0.12 52.2 (11.9) 53.7 (11.3) 53.2 (10.2) 0.47
BMI (kg/m
2) 27.2 (4.5) 26.9 (3.3) 26.6 (3.8) 0.55 27.5 (5.6) 25.4 (4.2) 24.6 (3.6) 0.001
No. of cigarettes/day 12.7 (10.2) 13.0 (7.0) 12.7 (5.2) 0.22 9.2 (7.0) 10.6 (4.6) 11.5 (5.7) <0.001
No. of years smoked 30.3 (12.1) 33.6 (11.6) 34.6 (12.1) 0.06 28.7 (11.2) 32.0 (10.3) 33.7 (9.6) 0.002
Values are given as means (standard deviation) and numbers (%)
BMI body mass index
aNumbers may vary due to missing information
bAnova and Kruskal-Wallis test for continuous variables. Pearson chi-square test for categorical variables
Eur J Clin Microbiol Infect Dis (2012) 31:465–473 469association between serum 25(OH)D and S. aureus nasal
colonization and carriage in non-smoking men with no such
clear association among women. Based on our findings, we
suggest that vitamin D can upregulate the antibacterial
immune response and thereby prevent S. aureus coloniza-
tion and carriage, and subsequent disease. Furthermore, we
hypothesize that the relative importance of vitamin D in this
context is particularly high in the male population who lack
female sex hormones known to boost the immune defence
[25–27]. S. aureus was significantly less frequent in
smokers than in non-smokers, and interestingly, serum 25
(OH)D levels did not vary by S. aureus colonization or
carriage states in smokers. These findings support that the
inverse association between vitamin D and S. aureus
colonization and carriage may be masked by smoking,
which is possibly explained by the bactericidal activity of
cigarette smoke [7] and the increased immune activity
associated with smoking-induced hypoxia.
This study is, to our knowledge, the first to report an
association between vitamin D levels and MSSA carriage in
a general population. However, in a recent study including
single nasal swab cultures from 14,000 children and adults
across the USA, an inverse association between vitamin D
levels and risk of MRSA was observed [9]. The microbe-
dependent association may partly be due to the increased
resistance of MRSA to natural antimicrobial peptides (i.e.
cathelicidin) induced by vitamin D in host defence against
S. aureus [28]. The apparent discrepancy with our MSSA
results may be explained by several factors. While in
Matheson et al. more detailed subgroup analysis was not
presented [9], we observed that gender and smoking status
may modify the association between vitamin D levels and
S. aureus colonization and carriage. Furthermore, our study
included men and women from a well-defined arctic adult
source population, 69°N, and there is minimal concern
about geographical and ethnical heterogeneity that, in
contrast, may have influenced the findings by Matheson et
al. [9].
The inverse dose-response relationship between vitamin
D status and S. aureus prevalence observed among non-
smokers in our study is in accordance with former findings
[9], and points to targets for reducing the reservoir of S.
aureus in the population, in particular when vitamin D
insufficiency is common. Carriage of S. aureus precedes
infection. Thus, our findings suggest that vitamin D
supplementation may reduce the incidence of MSSA and
Fig. 2 Probability of Staphylo-
coccus aureus colonization
and carriage in non-smoking
men (n=1,351 and n=992),
women (n=1,655 and n=1,239),
and total population (n=3,006
and n=2,231), respectively,
according to serum 25-
hydroxyvitamin D (25(OH)D)
level in nmol/l. Lines depict
regression line (navy) with
95% mean prediction interval
(grey area)
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D above 59 nmol/l and 75 nmol/l as thresholds for ~30%
and ~50% reduction in S. aureus colonization and carriage
in non-smoking men. Consensus to define a cut-point for
vitamin D insufficiency based on serum 25(OH)D levels is
lacking. Various cut-points have been proposed based on
population-based reference limits or biological indices as
parathyroid hormone, calcium absorption, or bone mineral
density, but without reference to immune function and
infectious diseases [29, 30]. Given the high risk of S.
aureus infection in combination with malnutrition in
specific patient populations (i.e. surgical, dialysis, ICU,
HIV [4]), and the fact that most of the infections are caused
by the patient’s nasal strain [3, 4], our finding suggests that
vitamin D repletion reaching serum 25(OH)D above 60–
75 nmol/l may be a significant alternative in the prevention
of hospital infections. A recent retrospective study includ-
ing 52 subjects with Clostridium difficile and S. aureus
infections showed a link between low vitamin D status and
adverse outcome [31]. Larger and prospective studies are
needed to determine a possible role of vitamin D
supplementation and repletion in relation to S. aureus
colonization, carriage and infection.
The inverse relationship between serum 25(OH)D
concentration and S. aureus colonization and carriage did
not reach statistical significance among women in our
study. It has been proposed that women are inherently
protected from infections by estrogens, which increase
immune function [25, 32]. A variety of immunocompetent
cells express estrogen receptors, which mediate the antimi-
crobial effects, i.e. regulating the expression of caspases
and cytokines [25–27]. Thus, we hypothesize that the
stable, low lifetime prevalence of S. aureus carriage in
women is mainly explained by endogenous estrogens that
may overwhelm the protective effect of vitamin D. The
observed gender difference is in accordance with studies of
Table 3 The Tromsø Staph and Skin Study. Estimated odds ratios (ORs) for S. aureus nasal colonization and carriage in non-smoking men and
women by serum 25(OH)D tertiles and categories
Swab culture Men Women
Single swab culture, 25(OH)D tertiles
25(OH)D (nmol/l) Total, n Colonized, n (%) OR
a (95% CI) OR
b (95% CI) Total, n Colonized, n (%) OR
a (95% CI) OR
b (95% CI)
<44.9 438 184 (42.0) 1.0 1.0 566 142 (25.1) 1.0 1.0
44.9–58.6 464 184 (39.7) 0.95 (0.73–1.24) 0.92 (0.70–1.21) 537 130 (24.2) 0.95 (0.73–1.25) 1.00 (0.76–1.32)
>58.6 449 138 (30.7) 0.66 (0.50–0.88) 0.65 (0.49–0.87) 552 131 (23.7) 0.93 (0.71–1.22) 0.99 (0.75–1.31)
p trend 0.004 0.004 0.60 0.94
Repeated swab culture, 25(OH)D tertiles
25(OH)D (nmol/l) Total, n Carriers, n (%) OR
a (95% CI) OR
b (95% CI) Total, n Carriers, n (%) OR
a (95% CI) OR
b (95% CI)
<44.9 329 123 (37.4) 1.0 1.0 431 96 (22.3) 1.0 1.0
44.9–58.6 346 129 (37.3) 1.06 (0.77–1.46) 1.04 (0.75–1.43) 390 83 (21.3) 0.94 (0.67–1.31) 1.02 (0.72–1.43)
>58.6 317 86 (27.1) 0.68 (0.49–0.96) 0.67 (0.48–0.95) 418 85 (20.3) 0.88 (0.63–1.23) 0.95 (0.68–1.33)
p trend 0.03 0.03 0.46 0.76
Single swab culture, 25(OH)D categories
25(OH)D (nmol/l) Total, n Colonized, n (%) OR
a (95% CI) OR
b (95% CI) Total, n Colonized, n (%) OR
a (95% CI) OR
b (95% CI)
<50.0 621 257 (41.4) 1.0 1.0 783 197 (25.2) 1.0 1.0
50.0–<75.0 603 215 (35.7) 0.81 (0.64–1.02) 0.80 (0.63–1.02) 713 171 (24.0) 0.94 (0.74–1.19) 1.0 (0.79–1.28)
>=75.0 127 34 (26.8) 0.57 (0.37–0.88) 0.54 (0.35–0.84) 159 35 (22.0) 0.84 (0.56–1.26) 0.88 (0.58–1.34)
p trend 0.006 0.004 0.38 0.68
Repeated swab culture, 25(OH)D categories
25(OH)D (nmol/l) Total, n Carriers, n (%) OR
a (95% CI) OR
b (95% CI) Total, n Carriers, n (%) OR
a (95% CI) OR
b (95% CI)
<50.0 471 177 (37.6) 1.0 1.0 592 134 (22.6) 1.0 1.0
50.0–<75.0 426 139 (32.6) 0.84 (0.64–1.12) 0.84 (0.63–1.11) 524 108 (20.6) 0.88 (0.66–1.17) 0.92 (0.69–1.23)
>=75.0 95 22 (23.2) 0.55 (0.33–0.92) 0.52 (0.31–0.90) 123 22 (17.9) 0.73 (0.44–1.21) 0.78 (0.47–1.29)
p trend 0.02 0.02 0.18 0.32
n numbers, CI confidence interval, OR odds ratio
aAge-adjusted
bMultivariate logistic regression model including: age, diabetes mellitus (yes/no), body mass index (BMI), seasonal month divided in 2 month
categories
Eur J Clin Microbiol Infect Dis (2012) 31:465–473 471other outcomes; type 2 diabetes and insulin resistance have
been associated with low vitamin D status in men only [33,
34], but so far these gender differences lack explanation.
Recent studies suggest that higher vitamin D status is
protective against upper respiratory tract infections [17, 18,
35], and that seasonal influenza might be linked to the
wintertime deficiency of vitamin D [15]. Furthermore,
vitamin D deficiency has been associated with increased
risk of tuberculosis (TB) [36] and immunomodulatory
effects of vitamin D and sunlight in TB therapy continue
to be revealed [16]. Importantly, however, a U-shaped
association between serum 25(OH)D concentration and risk
of active TB was recently observed [37], indicating that
vitamin D supplementation may have detrimental effects on
the immune function among individuals with normal or
high vitamin D status.
Our main findings may be biased by the positive
association between age and serum 25(OH)D among
non-smoking men; higher consumption of traditional
marine food like cod liver and fresh cod liver oil, more
frequent extended stays in the south, and lower BMI in
the elderly may contribute to this association (results not
presented). Also, in male participants, age is inversely
related to S. aureus nasal carriage [21] .B a s e do nt h i s ,w e
included age as a covariate in our regression analysis and
stratified by age group (i.e. tertiles) but observed no
interaction. However, in the middle-age tertile with
subjects relatively evenly distributed in serum 25(OH)D
levels and homogenous S. aureus frequencies across the
age range, the strength of the vitamin D–S. aureus
associations increased.
Thus, if there is an association between serum 25(OH)D
and risk of S. aureus colonization and carriage this could be
explained by the immunmodulatory effects of vitamin D. S.
aureus stimulates the conversion of 25-hydroxyvitamin D
(25(OH)D) to the active metabolite 1,25-dihydroxyvitamin
D (1,25(OH)2D) [12]. Vitamin D stimulates the production
of antimicrobial peptides (i.e. cathelicidin and β-defensin)
with activity against S. aureus [10], and contributes to the
formation of an intact epidermal barrier preventing S.
aureus invasion (i.e. regulation of keratinocytes) [11].
Interestingly, genetic polymorphisms in VDR in combina-
tion with type 1 diabetes has been associated with the risk
of S. aureus colonization and carriage [38, 39].
Detailed studies have shown that there are two carrier
states that differ in the immune response to S. aureus and
risk of infections; persistent carriers and others [23]. In our
study, culturing results of two repeated nasal swabs differed
only in a minor proportion of the participants (8%); thus
classification by colonization state almost equalled carrier
state. Many other similar studies have used only one sample
[7, 9]. Furthermore, the high participation rate and uniform
use of standard and validated clinical and laboratory
procedures increase the external validity of our findings
[22, 40].
The cross-sectional study design precludes establishing
temporality and thus causality of serum 25(OH)D concen-
trations and S. aureus colonization and carriage. Due to our
former studies indicating an overestimation of serum 25
(OH)D levels in smokers by the ECLIA (Roche) test [19],
we stratified by smoking status and included smoking data
as covariates in the analysis of the smoking population.
This strengthens the validity of the linear trend estimates.
However, estimation of externally valid cut-off values for
serum 25(OH)D in smokers is hindered.
In conclusion, our study indicates an inverse association
between serum 25(OH)D concentration and the risk of S.
aureus nasal colonization and carriage in non-smokers,
particularly in men. Prospective randomised trials are
needed to assess whether increase in circulating vitamin D
concentration can effectively decrease the risk of S. aureus
carriage and subsequent infection.
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